abagovomab 14
abciximab 23
abituzumab 6
abrilumab 0
actoxumab 6
adalimumab 7
aducanumab 3
afasevikumab 0
alacizumab_pegol 0
alemtuzumab 12
alirocumab 6
amatuximab 8
andecaliximab 9
anifrolumab 12
anrukinzumab 10
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 12
avelumab 5
basiliximab 10
bavituximab 6
begelomab 3
benralizumab 15
bevacizumab_beta 7
bezlotoxumab 6
bimagrumab 3
bleselumab 7
blinatumomab 14
blosozumab 10
bococizumab 12
brazikumab 10
brentuximab_vedotin 8
briakinumab 10
brodalumab 4
brolucizumab 14
brontictuzumab 8
burosumab 9
cabiralizumab 11
camrelizumab 3
canakinumab 8
cantuzumab_ravtansin 17
carlumab 12
carotuximab 3
cergutuzumab_amunaleukin2 16
cergutuzumab_amunaleukin 16
certolizumab_pegol 13
cetiximab 18
citatuzumab_bogatox 18
cixutumumab 16
clivatuzumab_tetraxetan 7
codrituzumab 15
conatumumab 10
concizumab 11
crenezumab 10
crizanlizumab 12
crotedumab 13
dacetuzumab 11
daclizumab 6
dalotuzumab 10
dapirolizumab_pegol 14
daratumumab 10
dectrekumab 7
demcizumab 10
denosumab 3
depatuxizumab 8
depatuxizumab_mafodotin 8
dezamizumab 10
dinutuximab 13
diridavumab 3
domagrozumab 0
drozitumab 11
duligotuzumab 10
durvalumab 7
dusigitumab 14
efalizumab 20
efungumab 6
eldelumab 10
elezanumab 3
elgemtumab 4
elotuzumab 10
emactuzumab 4
emapalumab 11
emibetuzumab 9
enavatuzumab 11
enfortumab_vedotin 3
enoblituzumab 10
enokizumab 10
enoticumab 9
ensituximab 10
eptinezumab 0
erenumab 10
etaracizumab 10
etrolizumab 18
evinacumab 7
evolocumab 6
farletuzumab 0
fasinumab 9
fezakinumab 10
fibatuzumab 6
ficlatuzumab 20
firivumab 14
flanvotumab 12
fletikumab 7
foralumab 8
foravirumab 11
fremanezumab 17
fresolimumab 9
fulranumab 11
futuximab 6
galcanezumab 8
ganitumab 12
gantenerumab 7
gemetuzumab 16
gemtuzumab2 9
gemtuzumab 8
gevokizumab 14
girentuximab 11
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 12
ibalizumab 16
ibritumomab 7
icrucumab 8
idarucizumab 20
ifabotuzumab 6
imalumab 8
imgatuzumab 17
inclacumab 9
indatuximab_ravtansin 16
indusatumab 9
inebilizumab 11
intetumumab 4
iodine_girentuximab 9
ipilimumab 4
iratumumab 0
isatuximab 16
itolizumab 0
ixekizumab 14
labetuzumab_govitecan 17
lambrolizumab 9
lampalizumab 15
lanadelumab 14
landogrozumab 0
laprituximab 7
lebrikizumab 15
lendalizumab 15
lenzilumab 10
lifastuzumab_vedotin 4
ligelizumab 9
lilotomab 14
lirilumab 10
lodelcizumab 13
lokivetmab 6
lorvotuzumab_mertansin 3
lucatumumab 6
lumretuzumab 14
lupartumab 6
lutikizumab 9
margetuximab 12
milatuzumab 9
mirvetuximab 16
mirvetuximab_soravtansin 16
modotuximab 13
mogamulizumab 12
monalizumab 13
motavizumab 19
moxetumomab_pasudotox 11
namilumab 13
naratuximab 7
naratuximab_emtansin 7
narnatumab 9
navicixizumab2 16
navicixizumab 10
navivumab 9
necitumumab 3
nemolizumab 19
nesvacumab 0
nivolumab 9
obiltoxaximab 5
obinutuzumab 18
ocaratuzumab 11
ofatumumab 11
olaratumab 4
olokizumab 13
omalizumab 13
onartuzumab 11
ontuxizumab 11
opicinumab 9
orticumab 0
otelixizumab 12
oxelumab 3
ozanezumab 12
pamrevlumab 3
panobacumab 17
parsatuzumab 15
pasotuxizumab 7
pateclizumab 8
patritumab 5
pembrolizumab 9
perakizumab 9
pidilizumab 5
pinatuzumab_vedotin 9
plozalizumab 11
pogalizumab 18
polatuzumab_vedotin 14
ponezumab 13
prezalumab 14
pritoxaximab 19
quilizumab 4
racotumomab 12
radretumab 5
ralpancizumab 16
ramucirumab 5
ranevetmab 13
ranibizumab 9
refanezumab 11
remtolumab 5
rilotumumab 10
rinucumab 5
risankizumab 7
rituximab 8
rivabazumab 13
robatumumab 10
roledumab 8
romosozumab 8
rontalizumab 15
rosmantuzumab 8
rozanolixizumab 10
sacituzumab 18
sacituzumab_govitecan 18
samalizumab 16
sapelizumab 8
sarilumab 0
secukinumab 8
seribantumab 4
setoxaximab 17
sifalimumab 6
siltuximab 7
simtuzumab 11
sirukumab 6
solanezumab 15
solitomab 13
stamulumab 4
suptavumab 15
suvizumab 11
tabalumab 8
tadocizumab 8
tamtuvetmab 8
tanezumab 17
tarextumab 3
tavolixizumab 0
telisotuzumab 13
teplizumab 9
tesidolumab 3
tezepelumab 14
tigatuzumab 9
tildrakizumab 14
timolumab 7
tisotumab 3
tosatoxumab 16
tositumomab 7
tralokinumab 22
trastuzumab 18
tregalizumab 8
trevogrumab 5
ublituximab 12
urelumab 9
ustekinumab 16
utomilumab 4
vadastuximab 6
vadastuximab_talirin 6
vandortuzumab_vedotin 7
vantictumab 16
vanucizumab2 7
vanucizumab 12
varlilumab 10
vatelizumab 7
vedolizumab 6
veltuzumab 3
vesencumab 7
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 14
xentuzumab 10
zatuximab 13
